Intravacc forms alliance to develop intranasal Covid-19 vaccine
Dutch research and development vaccine institute Intravacc has collaborated with Wageningen Bioveterinary Research (WBVR) and Utrecht University to develop an intranasal vaccine against Covid-19.
CSL teams up with CEPI and UQ for Covid-19 vaccine
Australia-based biotechnology company CSL has partnered with the Coalition for Epidemic Preparedness Innovations (CEPI) and the University of Queensland (UQ) to advance the university's Covid-19 vaccine.
Memo Therapeutics discovers neutralising antibodies against Covid-19
Switzerland-based Memo Therapeutics has discovered multiple SARS-CoV-2 neutralising antibodies with the potential for development as immunotherapy against Covid-19.
AstraZeneca teams up with Accent Therapeutics for cancer therapies
AstraZeneca has partnered with Accent Therapeutics for the discovery, development and commercialisation of new medicines to treat cancer.
Liposomes protect, transport and release your drug at the right place and time. By this, a reduced dose achieves better efficacy and avoids side effects with a non-invasive application. A liposomal formulation can clearly improve the therapeutic index of your drug.
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.